Molecular profiling confirms historical immunohistochemistry in acromegaly

in Endocrine-Related Cancer
View More View Less
  • 1 Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA
  • 2 Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada

Correspondence should be addressed to S L Asa: Sylvia.Asa@UHhospitals.org
Restricted access

 

      Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 115 115 115
Full Text Views 7 7 7
PDF Downloads 4 4 4
  • Asa SL & Perry A 2020 Tumors of the Pituitary Gland, AFIP Atlas of Tumor and Non-tumor Pathology, Series 5. Arlington, VA, USA: ARP Press.

  • Asa SL, Kucharczyk W & Ezzat S 2017 Pituitary acromegaly: not one disease. Endocrine-Related Cancer 24 C1C4. (https://doi.org/10.1530/ERC-16-0496)

    • Search Google Scholar
    • Export Citation
  • Bhayana S, Booth GL, Asa SL, Kovacs K & Ezzat S 2005 The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. Journal of Clinical Endocrinology and Metabolism 90 62906295. (https://doi.org/10.1210/jc.2005-0998)

    • Search Google Scholar
    • Export Citation
  • Ezzat S, Kontogeorgos G, Redelmeier DA, Horvath E, Harris AG & Kovacs K 1995 In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide. European Journal of Endocrinology 133 686690. (https://doi.org/10.1530/eje.0.1330686)

    • Search Google Scholar
    • Export Citation
  • Ezzat S, Caspar-Bell GM, Chik CL, Denis MC, Domingue , Imran SA, Johnson MD, Lochnan HA, Grégoire Nyomba BL, Prebtani A, 2019 Predictive markers for postsurgical medical management of acromegaly: a systematic review and consensus treatment guideline. Endocrine Practice 25 379393. (https://doi.org/10.4158/EP-2018-0500)

    • Search Google Scholar
    • Export Citation
  • Puig-Domingo M, Gil J, Sampedro-Nunez M, Jorda M, Webb SM, Serra G, Pons L, Salinas I, Blanco A, Marques-Pamies M, 2020 Molecular profiling for acromegaly treatment: a validation study. Endocrine-Related Cancer 27 375389. (https://doi.org/10.1530/ERC-18-0565)

    • Search Google Scholar
    • Export Citation
  • Qian ZR, Sano T, Yoshimoto K, Asa SL, Yamada S, Mizusawa N & Kudo E 2007 Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Modern Pathology 20 12691277. (https://doi.org/10.1038/modpathol.3800965)

    • Search Google Scholar
    • Export Citation
  • Sano T, Rong QZ, Kagawa N & Yamada S 2004 Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas. Frontiers of Hormone Research 32 127132. (https://doi.org/10.1159/000079041)

    • Search Google Scholar
    • Export Citation
  • Xu B, Sano T, Yoshimoto K & Yamada S 2002 Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies. Endocrine Pathology 13 341351. (https://doi.org/10.1385/ep:13:4:341)

    • Search Google Scholar
    • Export Citation